Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: A cluster randomised open-label trial

The Lancet

Volumn 386, Issue 10001, 2015, Pages 1362-1371

  Qadri, Firdausi ^a   Ali, Mohammad ^e   Chowdhury, Fahima ^a   Khan, Ashraful Islam ^a   Saha, Amit ^a   Khan, Iqbal Ansary ^a   Begum, Yasmin A ^a   Bhuiyan, Taufiqur R ^a   Chowdhury, Mohiul Islam ^a   Uddin, Md Jasim ^a   Khan, Jahangir A M ^a   Chowdhury, Atique Iqbal ^a   Rahman, Anisur ^a   Siddique, Shah Alam ^a   Asaduzzaman, Muhammad ^a   Akter, Afroza ^a   Khan, Arifuzzaman ^a   You, Young Ae ^c   Siddik, Ashraf Uddin ^a   Saha, Nirod Chandra ^a   Kabir, Alamgir ^a   Riaz, Baizid Khoorshid ^b   Biswas, Shwapon Kumar ^a   Begum, Farzana ^a   Unicomb, Leanne ^a   Luby, Stephen P ^f   Cravioto, Alejandro ^d   Clemens, John D ^a   more..

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b Sub Divisional Engineer Public works   (Bangladesh)

^c International Vaccine Institute   (South Korea)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; DRINKING WATER; INACTIVATED VACCINE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BANGLADESH; BEHAVIOR CHANGE; CHILD; CHOLERA; CONTROLLED STUDY; DEHYDRATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FEVER; ENDEMIC DISEASE; FEASIBILITY STUDY; FEMALE; HAND WASHING; HUMAN; INFECTION PREVENTION; INTERVENTION STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAFETY; TREATMENT RESPONSE; URBAN AREA; URBAN POPULATION; VACCINATION; VACCINATION REACTION; VERNER MORRISON SYNDROME; VOMITING; ADULT; CLUSTER ANALYSIS; HEALTH; HEALTH BEHAVIOR; HEALTH EDUCATION; INFANT; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BANGLADESH; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA VACCINES; CLUSTER ANALYSIS; ENDEMIC DISEASES; FEASIBILITY STUDIES; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HUMANS; INFANT; MALE; TREATMENT OUTCOME; URBAN HEALTH; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84944148040     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)61140-0     Document Type: Article

References (28)

1. M Ali, AL Lopez, Y You et al. The global burden of cholera Bull World Health Organ 90 2012 209 218
2. JB LR Harris, F Qadri, ET Ryan, SB Calderwood Cholera Lancet 379 2012 2466 2476
3. AR Sarker, Z Islam, IA Khan et al. Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective BMC Infect Dis 13 2013 518
4. WHO Cholera vaccines: WHO position paper Wkly Epidemiol Rec 85 2010 117 128
5. D Sur, S Kanungo, B Sah et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial PLoS Negl Trop Dis 5 2011 e1289
6. SK Bhattacharya, D Sur, M Ali et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial Lancet Infect Dis 13 2013 1050 1056
7. S Sridhar, NK Arora A rare success for cholera vaccines Lancet Infect Dis 13 2013 1000 1001
8. F Chowdhury, MA Rahman, YA Begum et al. Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh PLoS Negl Trop Dis 5 2011 e999
9. ME Halloran, CJ Struchiner, IM Longini Study designs for evaluating different efficacy and effectiveness aspects of vaccines Am J Epidemiol 146 1997 789 803
10. IA Khan, A Saha, F Chowdhury et al. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh Vaccine 31 2013 6058 6064
11. KR Hulland, E Leontsini, R Dreibelbis et al. Designing a handwashing station for infrastructure-restricted communities in Bangladesh using the integrated behavioural model for water, sanitation and hygiene interventions (IBM-WASH) BMC Public Health 13 2013 877
12. WHO The treatment of diarrhoea: a manual for physicians and other senior health workers (4th revision) 2005 World Health Organization Geneva
13. M Ansaruzzaman, NA Bhuiyan, GB Nair et al. Cholera in Mozambique, variant of Vibrio cholerae Emerg Infect Dis 10 2004 2057 2059
14. C Rodas, V Iniguez, F Qadri, G Wiklund, A-M Svennerholm, A Sjöling Development of multiplex PCR assays for detection of enterotoxigenic Escherichia coli colonization factors and toxins J Clin Microbiol 47 2009 1218 1220
15. AM WG Svennerholm Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin J Clin Microbiol 17 1983 596 600
16. AM Svennerholm, M Wikström, M Lindblad, J Holmgren Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay J Clinl Microbiol 24 1986 585 590
17. A Donner, N Klar Design and analysis of cluster randomization trials in health research 2000 Oxford University Press New York
18. ED Shapiro Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias Pediatr Infect Dis J 23 2004 127 131
19. S Kanungo, A Paisley, AL Lopez et al. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial Vaccine 27 2009 6887 6893
20. M Jertborn, AM Svennerholm, J Holmgren Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease J Clin Microbiol 24 1986 203 209
21. N Reid, H Crépeau Influence functions for proportional hazards regression Biometrika 72 1985 1 9
22. DY Lin, L-J Wei, Z Ying Checking the Cox model with cumulative sums of martingale-based residuals Biometrika 80 1993 557 572
23. DY Lin, L-J Wei The robust inference for the Cox proportional hazards model Biometrics 84 1989 1074 1078
24. EW Lee, LJ Wei, DA Amato, S Leurgans Cox-type regression analysis for large numbers of small groups of correlated failure time observations JP Klein P Goel Survival analysis: state of the art 1992 Springer 237 247
25. D Sur, AL Lopez, S Kanungo et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial Lancet 374 2009 1694 1702
26. T Wahed, SS Kaukab, NC Saha et al. Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka, Bangladesh BMC Public Health 13 2013 242
27. D Sinclair, K Abba, K Zaman, F Qadri, PM Graves Oral vaccines for preventing cholera Cochrane Database Syst Rev 2011 CD008603.
28. FJ Luquero, L Grout, I Ciglenecki et al. Use of Vibrio cholerae vaccine in an outbreak in Guinea N Engl J Med 370 2014 2111 2120